Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CNS Pharmaceuticals, Inc. - Common Stock (NQ:CNSP)

6.355 -0.185 (-2.83%)
Streaming Delayed Price Updated: 1:48 PM EDT, Aug 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CNS Pharmaceuticals, Inc. - Common Stock

< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
20 21 Next >
Why CNS Pharmaceuticals Shares Are Trading Higher Today
CNS Pharmaceuticals, Inc (NASDAQ: CNSP) shares gained after the company disclosed the stock purchase by CEO John M Climaco and director Jerzy Gumulka. 
Via Benzinga
US Stocks Mostly Flat; NY Empire State Manufacturing Index Surges In April
U.S. stocks traded mostly flat this morning, following the release of economic data. Following the market opening Monday, the Dow traded up 0.04% to 33,901.46 while the NASDAQ fell 0.09% to 12,112.19.... 
Via Benzinga
Splash Beverage Group And 2 Other Penny Stocks Insiders Are Aggressively Buying
The Dow Jones closed lower by more than 100 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
Why Marpai Shares Are Trading Lower By 26%; Here Are 20 Stocks Moving Premarket
Gainers CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) jumped 153% to $5.96 in pre-market trading after jumping 243% on Friday. 
Via Benzinga
CNS Pharmaceuticals Reports Full Year 2022 Financial Results and Provides Corporate Update
Via ACCESSWIRE
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
We're starting the week with a breakdown of the biggest pre-market stock movers traders need to know about on Monday morning! 
Via InvestorPlace
12 Health Care Stocks Moving In Friday's Intraday Session
 
Via Benzinga
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Global Trial Targets Unmet Medical Need in Arresting GBM Brain Cancer
Via Investor Brand Network
Study Explores Effects of MRI Scans During Cancer Treatment
Via Investor Brand Network
Why iMedia Brands Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
Gainers HeartCore Enterprises, Inc. (NASDAQ: HTCR) jumped 119.6% to $1.96 in pre-market trading. HeartCore forged an agreement with rYojbaba Inc for its tenth Go IPO consulting service win. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Pre-market stock movers are a hot topic on Wednesday as we dive into all of the latest news affecting markets this morning. 
Via InvestorPlace
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Enrolls First Patient in Switzerland in Its Potentially Pivotal Global GBM Trial, Reports No Exposure to SVB Issues
Via Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Enrolls Over 100 Patients in Potentially Pivotal Berubicin Study
Via Investor Brand Network
Over 100 Patients Now Enrolled in CNS Pharmaceuticals’ (NASDAQ: CNSP) Potentially Pivotal Study Evaluating Berubicin for the Treatment of Glioblastoma Multiforme (GBM)
Via ACCESSWIRE
12 Health Care Stocks Moving In Friday's After-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
Why Levi Strauss Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Liquid Media Group Ltd. (NASDAQ: YVR) jumped 88.1% to $0.2719. 
Via Benzinga
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Adds Italy to Growing Portfolio of Countries for Berubicin Study
Via Investor Brand Network
Why CNS Pharmaceuticals Shares Are Trading Higher
CNS Pharmaceuticals Inc (NASDAQ: CNSP) shares are trading higher by 15.47% to $1.00 after the company announced it received approval from the Competent Authority and the central Ethics Committee in... 
Via Benzinga
CNS Pharmaceuticals Receives Approval from Competent Authority and Central Ethics Committee in Italy for Potentially Pivotal Global Trial Evaluating Berubicin for the Treatment of GBM
Via ACCESSWIRE
Broad Cancer Analysis Finds Possibility for Tumor Reduction in Nearly All Cancers
Via Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces FY 2022 Results, Corporate Update
Via Investor Brand Network
AI Screens Brain Tumor Genes in Less Than Two Minutes
Via Investor Brand Network
Topics Artificial Intelligence
Stocks That Hit 52-Week Lows On Monday
  On Monday, 76 companies set new 52-week lows. 
Via Benzinga
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Participation in Upcoming Virtual Investor Event
Via Investor Brand Network
Lighting Up Malignant Tissues Could Boost Precision of Surgical Removal
Via Investor Brand Network
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Hits Key Milestone in Global GBM Clinical Trial with the Enrollment of First Patient in Spain
Via Investor Brand Network
Normalizing Blood Vessels in Tumors Could Improve Brain Cancer Immunotherapy
Via Investor Brand Network
Research Suggests Brain Cancers Could Be Detected Via Blood Tests
Via Investor Brand Network
Topics Death
< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
20 21 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.